| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.093 | 0.005 |
| mRNA | NSC632839 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.005 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.005 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.088 | 0.005 |
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.75 | 0.005 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.092 | 0.005 |